Opinion statement Neuroendocrine neoplasms (NEN) are a heterogeneous group of
tumours derived from cells of neuroendocrine origin and can potentially arise everywhere in …

Simple Summary Neuroendocrine neoplasms (NENs) are rare and heterogeneous tumors,
presenting in often challenging clinical scenarios, and require multidisciplinary discussion …

Neuroendocrine neoplasms (NEN) functional imaging is an evolving field that witnessed
major advances in the past two decades. The routine use of PET/CT with an array of new …

Neuroendocrine neoplasms (NEN) are rare and heterogeneous tumors, originating mostly
from the gastro-entero-pancreatic (GEP) tract followed by the lungs. Multidisciplinary …

Neuroendocrine tumours (NET) diagnosis has represented a major challenge in the past
decades. The introduction of somatostatin receptor scintigraphy in the diagnostic work-up …

Radiolabeled somatostatin analogs represent valuable tools for both in vivo diagnosis and
therapy of neuroendocrine tumors (NETs) because of the frequent tumoral overexpression of …

Neuroendocrine tumors (NETs) are relatively rare neoplasms arising from the hormone-
producing neuroendocrine system that can occur in various organs such as pancreas, small …

The diagnosis of neuroendocrine tumours (NETs) and monitoring of therapy in many
patients relies mainly on morphological imaging techniques such as computed tomography …

Neuroendocrine tumors (NETs) are rare group of neoplasms arising from nervous and
endocrine systems. Somatostatin analogue imaging is a functional imaging modality of …

Opinion statement Neuroendocrine tumors (NETs) are relatively rare, with 12,000–15,000
new cases diagnosed annually in the USA. Although NETs are a diverse group of …